The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 21, 2020
Filed:
May. 03, 2018
Applicant:
U.s. Nutraceuticals, Llc, Eustis, FL (US);
Inventors:
John A. Minatelli, Mount Dora, FL (US);
W. Stephen Hill, Ocala, FL (US);
Rudi E. Moerck, Sanford, FL (US);
Assignee:
U.S. NUTRACEUTICALS, LLC, Eustis, FL (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/728 (2006.01); A61K 31/122 (2006.01); A61K 36/9066 (2006.01); A61K 45/06 (2006.01); A61K 31/202 (2006.01); A61K 31/685 (2006.01); A61K 31/7028 (2006.01); A61K 36/05 (2006.01); A61K 36/185 (2006.01); A61K 36/324 (2006.01); A61K 36/74 (2006.01); A61K 9/48 (2006.01); A61K 35/60 (2006.01); A23L 33/115 (2016.01); A23L 33/12 (2016.01); A61K 31/7008 (2006.01); A23L 33/10 (2016.01); A61K 9/00 (2006.01); A61K 31/726 (2006.01); A61K 33/22 (2006.01); A61K 35/32 (2015.01); A61K 38/39 (2006.01); A61K 35/612 (2015.01);
U.S. Cl.
CPC ...
A61K 31/728 (2013.01); A23L 33/10 (2016.08); A23L 33/115 (2016.08); A23L 33/12 (2016.08); A61K 9/0053 (2013.01); A61K 9/4858 (2013.01); A61K 31/122 (2013.01); A61K 31/202 (2013.01); A61K 31/685 (2013.01); A61K 31/7008 (2013.01); A61K 31/7028 (2013.01); A61K 31/726 (2013.01); A61K 33/22 (2013.01); A61K 35/32 (2013.01); A61K 35/60 (2013.01); A61K 35/612 (2013.01); A61K 36/05 (2013.01); A61K 36/185 (2013.01); A61K 36/324 (2013.01); A61K 36/74 (2013.01); A61K 36/9066 (2013.01); A61K 38/39 (2013.01); A61K 45/06 (2013.01); A23V 2002/00 (2013.01);
Abstract
A dietary supplement composition is formulated in a therapeutic amount to treat and alleviate symptoms of joint pain. The composition includes pro-inflammatory low molecular weight microbial fermented sodium hyaluronate fragments having a molecular weight of 0.5 to 300 kilodaltons (kDa) in an oral dosage form.